Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats

Cytokine

Volumn 59, Issue 2, 2012, Pages 370-376

  Yang, Weina ^a   Wang, Junjian ^b   Shi, Lili ^a   Yu, Linhua ^a   Qian, Yihua ^a   Liu, Yong ^a   Wang, Weixi ^a   Cheng, Shaoli ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI AN CHILDREN S HOSPITAL   (China)

Author keywords

Focal segmental glomerulosclerosis; Nephrin; Proteinuria; Transforming growth factor beta 1; Vascular endothelial growth factor

Indexed keywords

NEPHRIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; WT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CELL COUNT; CELL DAMAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FOCAL GLOMERULOSCLEROSIS; GLOMERULAR SCLEROSIS INDEX; GLOMERULOSCLEROSIS; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MALE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RENAL SYSTEM PARAMETERS; SPRAGUE DAWLEY RAT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL COUNT; DOXORUBICIN; GLOMERULAR BASEMENT MEMBRANE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; KIDNEY DISEASES; MALE; MEMBRANE PROTEINS; PODOCYTES; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84862315740     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.014     Document Type: Article

References (35)

1. Ichikawa L., Ma J., Motojima M., Matsusaka T. Podocyte damage damages podocytes: autonomous vicious cycle that drives local spread of glomerular sclerosis. Curr Opin Nephrol Hypertens 2005, 14:205-210.
2. Asanuma K., Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 2003, 7:255-259.
3. Tryggvason K., Patrakka J., Wartiovaara J. Mechanisms of disease: hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006, 354:1387-1401.
4. Nakatsue T., Koike H., Han G.D., Suzuki K., Miyauchi N., Yuan H.P., et al. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int 2005, 67:2239-2253.
5. Kang Y.S., Li Y.J., Dai C.S., Kiss L.P., Wu C.Y., Liu Y.H. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 2010, 78:363-373.
6. Heikkila E., Juhila J., Lassila M., Messing M., Perala N., Lehtonen E., et al. Beta-Catenin mediates adriamycin-induced albuminuria and podocyte injury in adult mouse kidneys. Nephrol Dial Transplant 2010, 25:2437-2446.
7. Shankland S.J. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006, 69:2131-2147.
8. Pippin J.W., Brinkkoetter P.T., Cormack-Aboud F.C., Durvasula R.V., Hauser P.V., Kowalewska J., et al. Inducible rodent models of acquired podocyte diseases. Am J Physiol-Renal Physiol 2009, 296:F213-F229.
9. Monacci W.T., Merrill M.J., Oldfield E.H. Expression of vascular-permeability factor vascular endothelial growth-factor in normal rat-tissues. Am J Physiol 1993, 264:C995-C1002.
10. Fujimura T., Yamagishi S., Ueda S., Fukami K., Shibata R., Matsumoto Y., et al. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats. Nephrol Dial Transplant 2009, 24:1397-1406.
11. Fan Q.F., Xing Y., Ding J., Guan N. Reduction in VEGF protein and phosphorylated nephrin associated with proteinuria in adriamycin nephropathy rats. Nephron Exp Nephrol 2009, 111:E92-E102.
12. Veron D., Reidy K., Marlier A., Bertuccio C., Villegas G., Jimenez J., et al. Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephritic syndrome. Am J Pathol 2010, 177:2225-2233.
13. Abbate M., Zoja C., Morigi M., Rottoli D., Angioletti S., Tomasoni S., et al. Transforming growth factor-beta 1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins-A central pathway in progressive glomerulosclerosis. Am J Pathol 2002, 161:2179-2193.
14. Waiser J., Dell K., Kreutzkamp J., Bohler T., Budde K., Peters H., et al. FK506, transforming growth factor-beta 1 and mesangial matrix synthesis: parallels and differences compared with cyclosporine A. Cytokine 2006, 33:59-65.
15. Lopez-Hernandez F.J., Lopez-Novoa J.M. Role of TGF-beta in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 2012, 347:141-154.
16. Rodriguez-Iturbe B., Quiroz Y., Shahkarami A., Li Z., Vaziri N.D. Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat. Kidney Int 2005, 68:1041-1047.
17. Mundlos S., Pelletier J., Darveau A., Bachmann M., Winterpacht A., Zabel B., et al. Nuclear-localization of the protein encoded by the Wilms-tumor gene WT1 in embryonic and adult tissues. Development 1993, 119:1329-1341.
18. Su J., Li S.J., Chen Z.H., Zeng C.H., Zhou H., Li L.S., et al. Evaluation of podocyte lesion in patients with diabetic nephropathy: wilms' tumor-1 protein used as a podocyte marker. Diabetes Res Clin Pract 2010, 87:167-175.
19. White K.E., Bilous R.W. Estimation of podocyte number: a comparison of methods. Kidney Int 2004, 66:663-667.
20. Fukami K., Ueda S., Yamagishi S., Kato S., Inagaki Y., Takeuchi M., et al. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction. Kidney Int 2004, 66:2137-2147.
21. Liu H.F., Guo L.Q., Huang Y.Y., Hen K., Tao J.L., Li S.M., et al. Thiazolidinedione attenuate proteinuria and glomerulosclerosis in adriamycin-induced nephropathy rats via slit diaphragm protection. Nephrology 2010, 15:75-83.
22. Marshall C.B., Krofft R.D., Pippin J.W., Shankland S.J. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo. Am J Physiol-Renal Physiol 2010, 298:F1140-F1151.
23. Zou M.S., Yu J., Zhou J.H., Nie G.M., Ding D.S., Luo L.M., et al. 1,25-Dihydroxy-vitaminD(3) ameliorates podocytopenia in rats with adriamycin-induced nephropathy. Intern Med 2010, 49:2677-2686.
24. Wu Y.G., Dong J., Yuan L., Liang C., Ren K.J., Zhang W., et al. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine 2008, 44:85-91.
25. Lydia A., Asanuma K., Nonaka K., Takagi M., Jeong K.-H., Kodama F., et al. Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis. Am J Nephrol 2012, 35:58-68.
26. Appel D., Kershaw D.B., Smeets B., Yuan G., Fuss A., Frye B., et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009, 20:333-343.
27. Wolf G., Chen S.D., Ziyadeh F.N. From the periphery of the glomerular capillary wall toward the center of disease - Podocyte injury comes of age in diabetic nephropathy. Diabetes 2005, 54:1626-1634.
28. Iglesias-de la Cruz M.C., Ziyadeh F.N., Isono M., Kouahou M., Han D.C., Kalluri R., et al. Effects of high glucose and TGF-beta 1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 2002, 62:901-913.
29. Cui T.G., Foster R.R., Saleem M., Mathieson P.W., Gillatt D.A., Bates D.O., et al. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF(165)b) mRNA and protein. Am J Physiol-Renal Physiol 2004, 286:F767-F773.
30. Foster R.R., Hole R., Anderson K., Satchell S.C., Coward R.J., Mathieson P.W., et al. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol-Renal Physiol 2003, 284:F1263-F1273.
31. Lee H.S., Song C.Y. Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease. Histol Histopath 2009, 24:901-908.
32. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003, 111:707-716.
33. Zhang W., Li Q., Wang L.J., Yang X.Q. Simvastatin ameliorates glomerulosclerosis in adriamycin-induced-nephropathy rats. Pediatr Nephrol 2008, 23:2185-2194.
34. Schiffer M., Bitzer M., Roberts I.S.D., Kopp J.B., Dijke Pten, Mundel P., et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001, 108:807-816.
35. Asanuma K., Campbell K.N., Kim K., Faul C., Mundel P. Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes. Proc Natl Acad Sci USA 2007, 104:10134-10139.